Severe acute respiratory syndrome coronavirus 2 antibody prevalence in adult patients with short bowel syndrome-A German multicenter cross-sectional study.

Elisabeth BlüthnerUlrich-Frank PapeIrina BlumensteinJeanette WichmannFrank TackeMarkus A Feufel

Published in: JPEN. Journal of parenteral and enteral nutrition (2022)

These are the first clinical results concerning SARS-CoV-2 seropositivity and COVID-19 disease in patients with SBS. The seropositivity is comparable to national data, which we attribute to increased risk awareness and avoidance. Further studies are warranted to investigate effects of COVID-19 infection in SBS patients.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
risk factors
electronic health record
clinical trial
machine learning
cross sectional